Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
Cash Flows From Operating Activities | |||||
Net Income | 10,060,000 | 7,965,000 | 5,427,000 | 2,839,000 | 8,180,000 |
Depreciation Amortization | 2,093,000 | 1,586,000 | 1,063,000 | 515,000 | 2,124,000 |
Income taxes - deferred | -235,000 | -552,000 | -212,000 | 53,000 | -676,000 |
Accounts receivable | -599,000 | -670,000 | -893,000 | -617,000 | -108,000 |
Other Working Capital | -1,021,000 | -1,121,000 | -2,253,000 | -907,000 | 936,000 |
Other Operating Activity | 1,501,000 | 1,428,000 | 1,517,000 | 752,000 | 633,000 |
Operating Cash Flow | $11,799,000 | $8,636,000 | $4,649,000 | $2,635,000 | $11,089,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -2,478,000 | -1,338,000 | -797,000 | -320,000 | -1,938,000 |
Net Acquisitions | -987,000 | -747,000 | -693,000 | N/A | -580,000 |
Purchase Of Investment | -5,660,000 | -5,095,000 | -4,999,000 | -3,824,000 | -11,617,000 |
Sale Of Investment | 9,187,000 | 8,324,000 | 7,611,000 | 2,340,000 | 12,061,000 |
Other Investing Activity | -341,000 | -295,000 | -282,000 | -210,000 | -273,000 |
Investing Cash Flow | $-279,000 | $849,000 | $840,000 | $-2,014,000 | $-2,347,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 1,215,000 | 537,000 | 351,000 | 173,000 | 514,000 |
Debt Issued | 6,000 | 4,000 | 4,000 | 4,000 | 17,000 |
Debt Repayment | -196,000 | -196,000 | -20,000 | -17,000 | -395,000 |
Common Stock Issued | 774,000 | 592,000 | 455,000 | 285,000 | 684,000 |
Common Stock Repurchased | -1,717,000 | -1,164,000 | -988,000 | -654,000 | -1,384,000 |
Dividend Paid | -3,793,000 | -2,810,000 | -1,829,000 | -847,000 | -3,251,000 |
Other Financing Activity | -732,000 | -602,000 | -314,000 | -144,000 | -1,291,000 |
Financing Cash Flow | $-4,443,000 | $-3,639,000 | $-2,341,000 | $-1,200,000 | $-5,106,000 |
Exchange Rate Effect | -225,000 | -224,000 | -195,000 | -85,000 | 190,000 |
Beginning Cash Position | 9,203,000 | 9,203,000 | 9,203,000 | 9,203,000 | 5,377,000 |
End Cash Position | 16,055,000 | 14,825,000 | 12,156,000 | 8,539,000 | 9,203,000 |
Net Cash Flow | $6,852,000 | $5,622,000 | $2,953,000 | $-664,000 | $3,826,000 |
Free Cash Flow | |||||
Operating Cash Flow | 11,799,000 | 8,636,000 | 4,649,000 | 2,635,000 | 11,089,000 |
Capital Expenditure | -2,632,000 | -1,490,000 | -874,000 | -397,000 | -2,175,000 |
Free Cash Flow | 9,167,000 | 7,146,000 | 3,775,000 | 2,238,000 | 8,914,000 |